In CML, the Philadelphia chromosome (Ph) and the BCR-ABL fusion oncogene are primarily generated when chromosome 9 and chromosome 22 undergo a reciprocal translocation (t(9;22)), accounting for unlimited cell proliferation and resistance to apoptosis [153]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.